JAK2 V617F mutation in essential thrombocythemia: Clinical associations and long-term prognostic relevance.

被引：0
|
作者：
Wolanskyj, AP
Lasho, TL
Schwager, SM
McClure, RF
Wadleigh, M
Lee, SJ
Gilliland, DG
Tefferi, A
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
254
引用
收藏
页码：77A / 78A
页数：2
相关论文
共 50 条
  • [21] JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera
    Zhang, Sujiang
    Qiu, Hongxia
    Fischer, Bruce S.
    Li, Weida
    Duan, Limin
    Sun, Xuemei
    Xu, Wei
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 696 - 699
  • [22] Neutrophilia and the JAK2 V617F Mutation
    Langabeer, Stephen E.
    Haslam, Karl
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
  • [23] Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation
    Hattori, Norimichi
    Fukuchi, Kunihiko
    Nakashima, Hidetoshi
    Maeda, Takashi
    Adachi, Daisuke
    Saito, Bungo
    Yanagisawa, Kouji
    Matsuda, Isao
    Nakamaki, Tsuyoshi
    Gomi, Kunihide
    Tomoyasu, Shigeru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 181 - 188
  • [24] CONCURRENT JAK2 V617F MUTATION AND BCR-ABL REARRANGEMENT IN A ESSENTIAL THROMBOCYTHEMIA PATIENT
    Novella, E.
    Bernardi, M.
    Pomponi, E.
    Peotta, E.
    Rodeghiero, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 358 - 359
  • [25] Splenomegaly and the JAK2 V617F mutation
    Langabeer, Stephen E.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E45 - E46
  • [26] Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation
    Norimichi Hattori
    Kunihiko Fukuchi
    Hidetoshi Nakashima
    Takashi Maeda
    Daisuke Adachi
    Bungo Saito
    Kouji Yanagisawa
    Isao Matsuda
    Tsuyoshi Nakamaki
    Kunihide Gomi
    Shigeru Tomoyasu
    International Journal of Hematology, 2008, 88 : 181 - 188
  • [27] A Case Report on Coexisting JAK2 V617F and Calr exon 9 Mutation in Essential Thrombocythemia
    Rashid, Munazza
    Ahmed, Rifat Zubair
    Ahmed, Shariq
    Nadeem, Muhammad
    Ahmed, Nuzhat
    Shamsi, Tahir
    BLOOD, 2015, 126 (23)
  • [28] Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden
    Lee, A-Jin
    Kim, Sang-Gyung
    Nam, Jun Yeb
    Yun, Jaehum
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    BLOOD RESEARCH, 2021, 56 (04) : 259 - 265
  • [29] Clinical relevance of JAK2 (V617F) mutant allele burden
    Passamonti, Francesco
    Rumi, Elisa
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (01): : 7 - 10
  • [30] Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia
    De Stefano, Valerio
    Za, Tommaso
    Rossi, Elena
    Fiorini, Alessia
    Ciminello, Angela
    Luzzi, Claudia
    Chiusolo, Patrizia
    Sica, Simona
    Leone, Giuseppe
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (05): : 733 - 737
12345